Article
PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma.
Brain pathology (Zurich, Switzerland) - 1 Sept 2013
Phillips Joanna J, Aranda Derick, Ellison David W, Judkins Alexander R, Croul Sidney E, Brat Daniel J, Ligon Keith L, Horbinski Craig, Venneti Sriram, Zadeh Gelareh, Santi Mariarita, Zhou Shengmei, Appin Christina L, Sioletic Stefano, Sullivan Lisa M, Martinez-Lage Maria, Robinson Aaron E, Yong William H, Cloughesy Timothy, Lai Albert, Phillips Heidi S, Marshall Roxanne, Mueller Sabine, Haas-Kogan Daphne A, Molinaro Annette M, Perry Arie
Abstract excerpt
High-grade astrocytomas (HGAs), corresponding to World Health Organization grades III (anaplastic astrocytoma) and IV (glioblastoma; GBM), are biologically aggressive, and their molecular classification is increasingly relevant to clinical management. PDGFRA amplification is common in HGAs, although its prognostic significance remains unclear. Using fluorescence in situ hybridization (FISH), the most sensitive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
